Search clinical trials for: Original Zoledronic Acid

Total 24290 results

Aarhus University Hospital
University of Aarhus; Amgen

Completed

Treatment With Zoledronic Acid Subsequent to Denosumab in Osteoporosis (ZOLARMAB)

Osteoporosis

Denmark
Novartis Pharmaceuticals

Completed

Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older

Osteopenia

United States
Milton S. Hershey Medical Center
Novartis

Completed

Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) (CTIBL)

Breast Cancer

United States
Novartis Pharmaceuticals

Completed

Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture

Osteoporosis | Hip Fracture

United States, Germany
Susan L. Greenspan
National Institutes of Health (NIH); National Institute on Aging (NIA)

Recruiting

Romosozumab Use to Build Skeletal Integrity (RUBI)

Osteoporosis | Osteoporosis, Postmenopausal | Osteoporosis Fracture

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

Pain | Breast Cancer | Lung Cancer | Prostate Cancer | Metastatic Cancer

United States
Tufts Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure (ASTRID-HF)

Heart Failure | Muscle Atrophy

United States
Eli Lilly and Company

Completed

Observational Study of Somatropin Treatment in Children (GeNeSIS)

Growth Hormone (GH) Deficiency | Short Stature Homeobox Containing Gene (SHOX) Deficiency | SHOX Deficiency-related Disorder | Non-GH-deficient Growth Disorders
Hoffmann-La Roche
Roche Pharma AG

Terminated

Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma (COMPARE)

Multiple Myeloma

Germany
University of California, San Diego
National Institute of Nursing Research (NINR)

Completed

Culturally and Linguistically Adapted Physical Activity Intervention for Latinas

Inactivity

United States
Sarah Blaylock
VA Office of Research and Development

Completed

Increasing the Accessibility of a Falls Prevention Intervention for Community Dwelling Older Adults With Low Vision

Fall | Low Vision

United States
University of British Columbia
British Columbia Children's Hospital; Providence Health & Services

Completed

Evaluation of Smartphone Versions of VAS and NRS for Use in Adults (Panda)

Postoperative Pain

Canada
Bio-Strath AG
Zentrum für Adipositas- und Stoffwechselmedizin Winterthur GmbH

Unknown

Influence of a Food Supplement on the Gut Microbiome in Healthy Obese Women

Overweight

Switzerland
Novartis Pharmaceuticals

Completed

Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis

Prostate Cancer

United States
Institut für Klinische Krebsforschung IKF GmbH...
EUSA Pharma, Inc.

Recruiting

Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Leiomyosarcoma (DiTuSarc)

Leiomyosarcoma

Germany
Sheba Medical Center

Not yet recruiting

Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density

Spinal Cord Injuries | Osteoporosis Fracture
Karolinska Institutet

Unknown

Bisphosphonates for the Treatment of Seropositive Musculoskeletal Complaints (PREVENT RA)

Seropositive Muskuloskeletal Complaints
Shriners Hospitals for Children
Novartis

Completed

An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta (INFOI)

Osteogenesis Imperfecta

Canada
Vejle Hospital
Odense University Hospital; Novartis

Completed

Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer

Breast Cancer | Multiple Myeloma

Denmark
Virginia Commonwealth University
Novartis

Withdrawn

Phase 1 Study of Zoledronic Acid in Sickle Cell Disease

Sickle Cell Disease

United States
Novartis Pharmaceuticals

Completed

HORIZON-PFT: Pivotal Fracture Trial

Osteoporosis

United States, Germany
Second Affiliated Hospital, School of Medicine,...

Recruiting

Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

Lung Metastases | Tumor Necrosis

China
Children's Hospital of Eastern Ontario

Completed

Denosumab for the Treatment of Osteoporosis in Children: A Pilot Study

Osteoporosis

Canada
University of California, San Francisco
Novartis

Completed

Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer

United States
University of Wisconsin, Madison

Completed

Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer

Breast Cancer

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis

Osteoporosis

United States
Sun Yat-sen University
Novartis

Completed

Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis

Non Small Cell Lung Cancer | Bone Metastases | High NTX Level

China
Jiangxi University of Traditional Chinese Medicine

Active, not recruiting

A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community

Primary Hypertension

China
University of Louisville
James Graham Brown Cancer Center

Terminated

Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid

Multiple Myeloma

United States
University of Pittsburgh
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

Zoledronic Acid for Osteoporosis in the Elderly (ZEST)

Osteoporosis | Bone Loss | Fragility Fractures

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer

Prostate Cancer

United States
BioNTech SE
Pfizer

Withdrawn

A Study to Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and Children

COVID-19
Aksaray University
Lund University Hospital

Recruiting

FARE Augmentation of Proximal Femoral Fractures With CaS/HA and Systemic ZA

Hip Fractures | Trochanteric Fracture of Femur | Bone Density, Low | Osteoporotic Fracture of Femur

Turkey
Helse Stavanger HF
Helse-Bergen HF

Enrolling by invitation

Prospective Breast Cancer Biobanking (PBCB)

Breast Cancer

Norway
Institut Cancerologie de l'Ouest

Completed

ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma (GEMO)

Prostate Adenocarcinoma

France
Aarhus University Hospital

Recruiting

Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2)

Osteoporosis, Postmenopausal

Denmark
Shengjing Hospital
The People's Hospital of Liaoning Province; Liaoning Tumor Hospital & Institute

Recruiting

Study on Bisphosphonates Targeting Triple-negative Breast Cancer

Breast Cancer

China
University of East Anglia

Unknown

A Comparison of Accelerometers for Measuring Daily Activity in Sarcoid

Sarcoidosis

United Kingdom
Centre Hospitalier Universitaire de Nice

Completed

Stage I Multiple Myeloma Treatment (IFM-01-04)

Multiple Myeloma

France
University of Sydney
Novartis

Unknown

Osteonecrosis of the Hip and Bisphosphonate Treatment (BONES)

Osteonecrosis

Australia
Medical University of Vienna

Unknown

Use of Bisphosphonates in the Treatment of Osteopathy After Liver Transplantation

Liver Transplantation | Osteoporosis

Austria
Amgen

Completed

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Bone Metastases
Mel Shiuann-Sheng Lee
Novartis

Completed

Prevention of Periprosthetic Bone Loss After Total Hip Replacement by Annual Bisphosphonate Therapy

Functional Outcomes | Prevention of BMD Loss After THR | Serum Markers of Bone Turnover

Taiwan
University Hospital, Basel, Switzerland

Completed

Effect of Bile Acids on the Secretion of Satiation Peptides in Humans

Echolocation

Switzerland
University of Colorado, Denver

Recruiting

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

Carcinoma, Non-Small-Cell Lung

United States
Australian and New Zealand Intensive Care Research...

Recruiting

Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults (BoneZone)

Critical Illness | Osteoporosis

Australia, New Zealand
University of Guadalajara
Hospital Civil de Guadalajara

Completed

Efficacy of Zoledronic Acid + Colaren vs Zoledronic Acid + Conventional Treatment for Osteoporosis in HIV+ and HIV- Men (OSZCO)

Secondary Osteoporosis

Mexico
Assistance Publique Hopitaux De Marseille

Completed

Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid

Hutchinson-Gilford Progeria Syndrome

France
Novartis

Completed

Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy

Breast Cancer

Canada
Boston Children's Hospital
Merck Sharp & Dohme LLC; Schering-Plough; Eiger BioPharmaceuticals

Active, not recruiting

Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

Progeria

United States

Search clinical trials for: Original Zoledronic Acid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations